74 related articles for article (PubMed ID: 31788047)
21. Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway.
Wang L; Li B; Bo X; Yi X; Xiao X; Zheng Q
Exp Mol Med; 2022 Jun; 54(6):848-860. PubMed ID: 35764883
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract][Full Text] [Related]
23. Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma.
Wang F; Breslin S J P; Qiu W
Liver Res; 2021 Dec; 5(4):195-203. PubMed ID: 34900376
[TBL] [Abstract][Full Text] [Related]
24. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
[TBL] [Abstract][Full Text] [Related]
25. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
Li J; Diao H; Guan X; Tian X
Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
[TBL] [Abstract][Full Text] [Related]
26. Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis.
He S; Yang J; Jiang S; Li Y; Han X
Cancer Cell Int; 2020; 20():404. PubMed ID: 32863763
[TBL] [Abstract][Full Text] [Related]
27. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
Wright N; Gong Z; Kittles R; Natarajan R; Jovanovic-Talisman T; Rida P; LaBarge M; Seewaldt V
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945833
[TBL] [Abstract][Full Text] [Related]
28. KIFC1 promotes the proliferation of hepatocellular carcinoma
Wang X; Wang M; Li XY; Li J; Zhao DP
Oncol Lett; 2019 Dec; 18(6):5739-5746. PubMed ID: 31788047
[TBL] [Abstract][Full Text] [Related]
29. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
30. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
[TBL] [Abstract][Full Text] [Related]
31. KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma.
Sun YF; Wu HL; Shi RF; Chen L; Meng C
Anal Cell Pathol (Amst); 2020; 2020():6403012. PubMed ID: 32318326
[TBL] [Abstract][Full Text] [Related]
32. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
33. Systemic treatment for hepatocellular carcinoma.
Aggarwal M; Arain A; Jin Z
Chronic Dis Transl Med; 2018 Sep; 4(3):148-155. PubMed ID: 30276361
[TBL] [Abstract][Full Text] [Related]
34. KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Han J; Wang F; Lan Y; Wang J; Nie C; Liang Y; Song R; Zheng T; Pan S; Pei T; Xie C; Yang G; Liu X; Zhu M; Wang Y; Liu Y; Meng F; Cui Y; Zhang B; Liu Y; Meng X; Zhang J; Liu L
Oncogene; 2019 Jan; 38(3):406-420. PubMed ID: 30115976
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
